Lycia Therapeutics, Inc. (LYCA)

NASDAQ

$26.16

$-2.62

(-9.08%)

Previous Close: ⁦$28.85⁩

Market Closed

Lycia Therapeutics, Inc. (LYCA) Live Price Chart

Last updated: ⁦2026-10-28 00:14:00⁩. Prices reflect the latest closing data and will resume updating on the next trading day. Stock price data is sourced from Massive.

Summary

Lycia Therapeutics, Inc. (LYCA) operates in the -- sector and is listed on NASDAQ. The stock is currently priced at $26.16, with a market capitalization of $1.56B and a P/E ratio of --. Over the past 52 weeks, its price has ranged from $22.19 to $36.49. This page covers its latest market performance, valuation, price trends and company information.

Key Market Data

Market Cap	$1.56B
Open	$26.51
Day's High	$36.49
Day's Low	$22.19
Previous Close	$28.85
Volume	404.82K
Average Volume	1.63M
P/E Ratio	--
52-Week High	$36.49
52-Week Low	$22.19
Dividend Yield	--
Earnings Date	--

Lycia Therapeutics, Inc. (LYCA) Latest Closing Stock Price

Lycia Therapeutics, Inc. (LYCA) last closed at $28.85 as of 2026-10-27 23:58:00, unchanged from the previous close of $28.85.

During the latest regular trading session, LYCA traded between $22.19 and $36.49, with a volume of 404.82K shares. The closing price was near the middle and near the lower end of its 52-week range.

Lycia Therapeutics, Inc. (LYCA) 7-Day Stock Price Change

Over the past seven days, Lycia Therapeutics, Inc. (LYCA) moved from $30.00 to $26.16, representing a decline of 12.79% ($3.84).

The stock traded between $22.19 and $36.49 during the period. The latest price is near the lower end of the 7-day range, indicating strong downward.

The average daily volume was 1.63 million shares, -- versus the previous seven-day period, indicating -- trading activity.

LYCA 52-Week Price Position

Position in Range: 27.8%

52W Low$22.19

52W High$36.49

LYCA is currently trading at $26.16, placing it 27.8% of the way from its 52-week low of $22.19 to its 52-week high of $36.49. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.

What is Lycia Therapeutics, Inc. (LYCA)?

Lycia Therapeutics Inc is a clinical-stage biotechnology company focused on the discovery and development of novel therapeutics designed to degrade disease-causing extracellular proteins, with an initial focus on addressing autoimmune, inflammatory and allergic diseases.

Lycia Therapeutics, Inc. Information

Exchange	NASDAQ
Company Website	https://www.lyciatx.com

How to Buy Lycia Therapeutics, Inc. (LYCA) Stock on MEXC

Eligible investors can buy real shares of Lycia Therapeutics, Inc. (LYCA) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.

Step 1: Open and Verify Your RealStocks Account

Log in to the MEXC App, go to Trade → RealStocks, and select Open Account. Complete the required account-opening and identity verification process with MEXC's partner licensed broker.

Step 2: Transfer USDT to Your RealStocks Account

Go to Wallets → RealStocks and transfer USDT from your Spot Account to your RealStocks Account. RealStocks are quoted in USD, while account funding can be completed using USDT.

Step 3: Search for LYCA and Place Your Order

Open the RealStocks trading page and search for LYCA. Select a market or limit order, enter the price and quantity as required, review the order details, and submit your order. Once filled, the corresponding real shares will be held in your RealStocks Account.

Frequently Asked Questions (FAQ)

1.What is Lycia Therapeutics, Inc. (LYCA) stock price today?

Lycia Therapeutics, Inc. (LYCA) is currently trading at $ 26.16, down 9.31% ($2.69) from the previous close of $ 28.85. Intraday prices update in real time during regular trading hours.

2.Is LYCA stock going up or down today?

As of 2026-10-27 23:58:00, LYCA is trading at $ 26.16, down 9.31% ($2.69) from its previous close of $ 28.85. The stock has traded between $ 22.19 and $ 36.49 during today’s regular session. Past price movements do not guarantee future results.

3.What is LYCA pre-market price?

As of 2026-10-27 23:58:00, LYCA is trading at $ 26.40 in pre-market trading, down 8.49% ($2.45) from the previous close of $ 28.85. Pre-market prices reflect trading activity before the regular session opens and may experience lower liquidity and higher volatility.

4.What is LYCA after-hours price?

As of 2026-10-27 23:58:00, LYCA is trading at $ 26.11 in after-hours trading, down 9.49% ($2.74) from the regular-session close of $ 28.85. After-hours prices may differ from the regular session’s opening price due to lower liquidity and wider bid-ask spreads.

5.Is LYCA stock trading now?

LYCA trades on the NASDAQ exchange during regular hours, Monday through Friday, 9:30 AM to 4:00 PM ET, excluding public holidays. Pre-market and after-hours trading are also available through select brokers outside these hours.

6.Where does LYCA sit relative to its 52-week high and low?

Over the past 52 weeks, LYCA has traded between a low of $ 22.19 and a high of $ 36.49. At $ 26.16, the stock is positioned 27.8% of the way from its 52-week low to its 52-week high, providing context for its current price within the one-year trading range.

7.What sector is Lycia Therapeutics, Inc. in?

Lycia Therapeutics, Inc. (LYCA) operates in the -- sector. Sector classification helps investors compare it with companies exposed to similar market trends and competitive conditions.

8.What is Lycia Therapeutics, Inc.'s market capitalization and where is it listed?

Lycia Therapeutics, Inc. is listed on the NASDAQ exchange with a market capitalization of $ 1.56B. Market cap reflects the total market value of all outstanding shares and is commonly used to classify stocks by size.

9.How is LYCA valued in terms of P/E ratio and EPS?

LYCA trades at a P/E ratio of --, based on trailing-twelve-month EPS of --. P/E ratio compares the stock price to earnings per share and is a common starting point for assessing valuation relative to peers.

10.Does Lycia Therapeutics, Inc. pay a dividend?

Lycia Therapeutics, Inc. pays an indicated annual cash dividend of -- per share, with a current dividend yield of --% based on the latest share price. Dividend policies are subject to change at the board's discretion.